DNA & Genetics City Therapeutics Pursues ‘Next Generation of RNAi’By adminFebruary 26, 20260 [L-R] Baisong Mei, Anna O’Driscoll chat with City Therapeutics CEO Andy Orth. City Therapeutics, a startup whose co-founders include RNA…
DNA & Genetics Genentech, SanegeneBio Launch Up-to-$1.7B RNAi CollaborationBy adminFebruary 3, 20260 A SanegeneBio researcher at work in the company’s lab. Genentech, a member of the Roche Group, will apply SanegeneBio’s RNA…
Microbiome JPM 2026: Corsera’s Rena Denoncourt and Meredith Kaya on Annual RNAi for Heart HealthBy adminJanuary 26, 20260 In late 2024, Corsera Health came up with a big, hairy, audacious goal thesis: cardiovascular disease, the world’s leading…
Longevity Aerska emerges from stealth to combat brain diseases with RNAiBy adminOctober 1, 20250 Startup’s ‘brain shuttle’ tech is designed to efficient, repeatable delivery of genetic medicines across the blood–brain barrier. Irish biotech Aerska…
